The Breakroom Video Series


In this chapter, Dr. Lyle and Dr. Husain discuss improving detection of EGFR insertion mutation using NGS. Dr. Husain says that PCR can miss more than 50% of EGFR Exon 20 Insertion mutations.

Dr. Lyle and Dr. Husain both understand clinical guidelines to recommend utilizing next-gen sequencing (NGS) for broad molecular profiling to test for biomarkers in lung cancers.

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients